Company Overview of AbSci, LLC
AbSci, LLC develops protein production technologies for the biopharmaceutical industry. The company offers SoluPro, a genetically engineered E. coli-based expression system that enables optimizable and scalable production of antibodies, antibody fragments, and other soluble recombinant proteins to be produced at a fraction of their current cost. Its therapeutic proteins and antibodies are used in cancer and hormone therapies, as well as autoimmune and blood disorder therapies. The company was founded in 2011 and is based in Portland, Oregon.
4640 SW Macadam Avenue
Portland, OR 97239
Founded in 2011
Key Executives for AbSci, LLC
AbSci, LLC Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact AbSci, LLC, please visit www.abscibio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.